These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17654590)

  • 1. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts.
    Morse DL; Raghunand N; Sadarangani P; Murthi S; Job C; Day S; Howison C; Gillies RJ
    Magn Reson Med; 2007 Aug; 58(2):270-80. PubMed ID: 17654590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.
    Morse DL; Carroll D; Day S; Gray H; Sadarangani P; Murthi S; Job C; Baggett B; Raghunand N; Gillies RJ
    NMR Biomed; 2009 Jan; 22(1):114-27. PubMed ID: 19016452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
    Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
    NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
    Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
    Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
    Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
    Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of phosphocholine and glycerophosphocholine with 31P edited 1H NMR spectroscopy.
    Loening NM; Chamberlin AM; Zepeda AG; Gonzalez RG; Cheng LL
    NMR Biomed; 2005 Nov; 18(7):413-20. PubMed ID: 16075415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative (31)P HR-MAS MR spectroscopy for detection of response to PI3K/mTOR inhibition in breast cancer xenografts.
    Esmaeili M; Bathen TF; Engebråten O; Mælandsmo GM; Gribbestad IS; Moestue SA
    Magn Reson Med; 2014 Jun; 71(6):1973-81. PubMed ID: 23878023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
    Brandes AH; Ward CS; Ronen SM
    Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.
    Jordan BF; Black K; Robey IF; Runquist M; Powis G; Gillies RJ
    NMR Biomed; 2005 Nov; 18(7):430-9. PubMed ID: 16206237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.
    Ward CS; Eriksson P; Izquierdo-Garcia JL; Brandes AH; Ronen SM
    PLoS One; 2013; 8(4):e62610. PubMed ID: 23626839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
    Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
    NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.
    Amstalden van Hove ER; Blackwell TR; Klinkert I; Eijkel GB; Heeren RM; Glunde K
    Cancer Res; 2010 Nov; 70(22):9012-21. PubMed ID: 21045154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
    Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
    J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.
    Klomp DW; van de Bank BL; Raaijmakers A; Korteweg MA; Possanzini C; Boer VO; van de Berg CA; van de Bosch MA; Luijten PR
    NMR Biomed; 2011 Dec; 24(10):1337-42. PubMed ID: 21433156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells.
    Gillies RJ; Barry JA; Ross BD
    Magn Reson Med; 1994 Sep; 32(3):310-8. PubMed ID: 7984063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.
    Valonen PK; Griffin JL; Lehtimäki KK; Liimatainen T; Nicholson JK; Gröhn OH; Kauppinen RA
    NMR Biomed; 2005 Jun; 18(4):252-9. PubMed ID: 15884096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
    McPhail LD; Chung YL; Madhu B; Clark S; Griffiths JR; Kelland LR; Robinson SP
    Clin Cancer Res; 2005 May; 11(10):3705-13. PubMed ID: 15897567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.
    Sah RG; Sharma U; Parshad R; Seenu V; Mathur SR; Jagannathan NR
    Magn Reson Med; 2012 Oct; 68(4):1039-47. PubMed ID: 22213087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proof-of-the-Concept Study on Mathematically Optimized Magnetic Resonance Spectroscopy for Breast Cancer Diagnostics.
    Belkić D; Belkić K
    Technol Cancer Res Treat; 2015 Jun; 14(3):277-97. PubMed ID: 25246518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.